Search research articles
Contact Us
Filters
Showing results (41-50 of 132) with videos related to
Page
of 14
Sort By:
Life (Basel, Switzerland)
|
December 24, 2021
Methylglyoxal Levels in Human Colorectal Precancer and Cancer: Analysis of Tumor and Peritumor Tissue
Chu-Kuang Chou, Po-Chun Yang, Pei-Yun Tsai, et al.
Hepato-Gastroenterology
|
November 8, 2006
Comparative study of modified-release clarithromycin and immediate-release clarithromycin in the treatment of Helicobacter pylori-associated peptic ulcer disease
Jyh-Ming Liou, Chi-Yi Chen, Ming-Shiang Wu, et al.
Journal of Medical Virology
|
April 26, 2007
Characterization of viral kinetics in patients with hepatitis B e antigen-positive chronic hepatitis B
I-Chin Wu, Nan-Haw Chow, Pin-Nan Cheng, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
August 2, 2022
Accuracy of simultaneous measurement of serum biomarkers: Carbohydrate antigen 19-9, pancreatic elastase-1, amylase, and lipase for diagnosing pancreatic ductal adenocarcinoma
Chi-Ying Yang, Ro-Ting Lin, Chi-Yi Chen, et al.
Journal of Gastroenterology and Hepatology
|
December 21, 2013
Higher adherence with 3-year entecavir treatment than lamivudine or telbivudine in treatment-naïve Taiwanese patients with chronic hepatitis B
Rong-Nan Chien, Cheng-Yuan Peng, Jia-Horng Kao, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi
|
June 6, 2020
Elbasvir/grazoprevir is effective and tolerable for the treatment of HCV GT1-infected patients: A real world multicenter observatory study in Taiwan
Pin-Nan Cheng, Chi-Yi Chen, Ming-Lung Yu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 5, 2021
Entecavir Prevents HBV Reactivation During Direct Acting Antivirals for HCV/HBV Dual Infection: A Randomized Trial
Pin-Nan Cheng, Chun-Jen Liu, Chi-Yi Chen, et al.
American Journal of Cancer Research
|
March 10, 2023
Prediction model of hepatocellular carcinoma in patients with hepatitis B virus-related compensated cirrhosis receiving antiviral therapy
Hung-Wei Wang, Chi-Yi Chen, Hsueh-Chou Lai, et al.
Medicina (Kaunas, Lithuania)
|
April 23, 2022
Factors Associated with the Refusal of Direct-Acting Antiviral Agents for the Treatment of Hepatitis C in Taiwan
Li-Jen Chang, Han-Cheng Chang, Po-Yueh Chen, et al.
Gastroenterology
|
January 7, 2022
Inhibition of Viral Replication Reduces Transcriptionally Active Distinct Hepatitis B Virus Integrations With Implications on Host Gene Dysregulation
Yao-Chun Hsu, Vithika Suri, Mindie H Nguyen, et al.
Page
of 14
Search research articles
Search
Showing results (41-50 of 132) with videos related to
Sort By:
Page
of 14
Life (Basel, Switzerland)
|
December 24, 2021
Methylglyoxal Levels in Human Colorectal Precancer and Cancer: Analysis of Tumor and Peritumor Tissue
Chu-Kuang Chou, Po-Chun Yang, Pei-Yun Tsai, et al.
Hepato-Gastroenterology
|
November 8, 2006
Comparative study of modified-release clarithromycin and immediate-release clarithromycin in the treatment of Helicobacter pylori-associated peptic ulcer disease
Jyh-Ming Liou, Chi-Yi Chen, Ming-Shiang Wu, et al.
Journal of Medical Virology
|
April 26, 2007
Characterization of viral kinetics in patients with hepatitis B e antigen-positive chronic hepatitis B
I-Chin Wu, Nan-Haw Chow, Pin-Nan Cheng, et al.
Journal of the Formosan Medical Association = Taiwan Yi Zhi
|
August 2, 2022
Accuracy of simultaneous measurement of serum biomarkers: Carbohydrate antigen 19-9, pancreatic elastase-1, amylase, and lipase for diagnosing pancreatic ductal adenocarcinoma
Chi-Ying Yang, Ro-Ting Lin, Chi-Yi Chen, et al.
Journal of Gastroenterology and Hepatology
|
December 21, 2013
Higher adherence with 3-year entecavir treatment than lamivudine or telbivudine in treatment-naïve Taiwanese patients with chronic hepatitis B
Rong-Nan Chien, Cheng-Yuan Peng, Jia-Horng Kao, et al.
Journal of Microbiology, Immunology, and Infection = Wei Mian Yu Gan Ran Za Zhi
|
June 6, 2020
Elbasvir/grazoprevir is effective and tolerable for the treatment of HCV GT1-infected patients: A real world multicenter observatory study in Taiwan
Pin-Nan Cheng, Chi-Yi Chen, Ming-Lung Yu, et al.
Clinical Gastroenterology and Hepatology : the Official Clinical Practice Journal of the American Gastroenterological Association
|
December 5, 2021
Entecavir Prevents HBV Reactivation During Direct Acting Antivirals for HCV/HBV Dual Infection: A Randomized Trial
Pin-Nan Cheng, Chun-Jen Liu, Chi-Yi Chen, et al.
American Journal of Cancer Research
|
March 10, 2023
Prediction model of hepatocellular carcinoma in patients with hepatitis B virus-related compensated cirrhosis receiving antiviral therapy
Hung-Wei Wang, Chi-Yi Chen, Hsueh-Chou Lai, et al.
Medicina (Kaunas, Lithuania)
|
April 23, 2022
Factors Associated with the Refusal of Direct-Acting Antiviral Agents for the Treatment of Hepatitis C in Taiwan
Li-Jen Chang, Han-Cheng Chang, Po-Yueh Chen, et al.
Gastroenterology
|
January 7, 2022
Inhibition of Viral Replication Reduces Transcriptionally Active Distinct Hepatitis B Virus Integrations With Implications on Host Gene Dysregulation
Yao-Chun Hsu, Vithika Suri, Mindie H Nguyen, et al.
Page
of 14